A comprehensive view of respiratory/lung health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer and BioNTech get FDA emergency use authorization for Omicron-adapted bivalent COVID-19 vaccine in children under 5 years; many states report over 90% of pediatric beds are occupied due to COVID-19 cases, rise in seasonal respiratory illnesses
Published: December 08, 2022 by Business Wire
FDA accepts for priority review the BLA for Pfizer’s respiratory syncytial virus vaccine candidate for the prevention of RSV disease in older adults
Published: December 07, 2022 by Pfizer Inc.
AstraZeneca signs US$402.0M global licensing agreement with C4XD for its NRF2 activator program; AstraZeneca to oversee development, commercialization of oral treatment for chronic obstructive pulmonary disease, other inflammatory and respiratory diseases
Published: November 28, 2022 by PharmaTimes
Study reports similar efficacy of dynamic digital radiography of the chest with lung ventilation perfusion for detection of chronic thromboembolic pulmonary hypertension: Konica Minolta Healthcare Americas
Published: November 23, 2022 by ICT Monitor Worldwide
Study finds early lung cancer scanning drastically improves survival rate, which currently stands at 18.6% for all lung cancer patients; American Cancer Society estimates there will be 236,000 new cases of lung cancer in US this year: Mount Sinai Hospital
Published: November 22, 2022 by FiercePharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count